Equities

Enhabit Inc

Enhabit Inc

Actions
Health CareHealth Care Providers
  • Price (USD)8.24
  • Today's Change0.08 / 0.98%
  • Shares traded860.38k
  • 1 Year change-31.33%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 23:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments27235.40
Total Receivables, Net168161165
Total Inventory------
Prepaid expenses13246.30
Other current assets, total2.404.302.60
Total current assets210212179
Property, plant & equipment, net776269
Goodwill, net1,0621,1451,189
Intangibles, net80103259
Long term investments------
Note receivable - long term------
Other long term assets5.305.2024
Total assets1,4341,5271,720
LIABILITIES
Accounts payable7.603.803.50
Accrued expenses595781
Notes payable/short-term debt000
Current portion long-term debt/capital leases23235.00
Other current liabilities, total494947
Total current liabilities138133137
Total long term debt5305603.50
Total debt5535838.50
Deferred income tax172963
Minority interest323413
Other liabilities, total473034
Total liabilities764785250
SHAREHOLDERS EQUITY
Common stock0.500.500.10
Additional paid-in capital4164071,095
Retained earnings (accumulated deficit)255335375
Treasury stock - common(0.6)----
Unrealized gain (loss)------
Other equity, total(0.5)(0.7)--
Total equity6707421,470
Total liabilities & shareholders' equity1,4341,5271,720
Total common shares outstanding505050
Treasury shares - common primary issue0.1100
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.